GMED: Globus Medical, Inc. - Summary | Jitta

Globus Medical, Inc.

NYSE:GMED

Price
$74.95
Loss Chance
47.5%
5.17JITTA SCORE
409.85%Over Jitta Line
Jitta Ranking
130 / 1,197
1,685 / 5,062
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (48)
Recent Business Performance (31)
Financial Strength (90)
Return to Shareholders (35)
Competitive Advantage (55)
Jitta Signs
Revenue and EarningConsistent
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Operating MarginInconsistent
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.17
409.85%
2.00
242.70%
Health Care Equipment
5.45
182.17%
6.90
110.97%
6.13
12.54%
COMPANY DESCRIPTION
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.